Recent Analyst Forecasts and Stock Ratings
Acrivon Therapeutics, Inc. Common Stock FAQ's
What analysts cover Acrivon Therapeutics, Inc. Common Stock?
Acrivon Therapeutics, Inc. Common Stock has been rated by research analysts at BMO Capital, Oppenheimer, H.C. Wainwright, Piper Sandler, JMP Securities, Jefferies in the past 90 days.